MDGL MADRIGAL PHARMACEUTICALS INC

Ownership history in Walleye Trading LLC  ·  38 quarters on record

This page tracks every 13F SEC filing in which Walleye Trading LLC reported a position in MADRIGAL PHARMACEUTICALS INC (MDGL). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.02% (2022 Q3)
Avg. % of fund
0.0%
First filed
2018 Q3
Last filed
2025 Q4
Quarters held
38
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 REDUCED 214 -286 -57.2% 0.00% $125K $582.34
2025 Q4 REDUCED 500 -1,300 -72.2% 0.00% $291K $582.34
2025 Q3 ADDED 1,800 +1,100 +157.1% 0.00% $826K $458.66
2025 Q3 REDUCED 700 -1,000 -58.8% 0.00% $321K $458.66
2024 Q4 REDUCED 1,700 -18,700 -91.7% 0.00% $525K $308.57
2024 Q4 ADDED 20,400 +19,600 +2450.0% 0.01% $6.3M $308.57
2024 Q1 REDUCED 800 -500 -38.5% 0.00% $214K $267.04
2024 Q1 REDUCED 1,300 -1,200 -48.0% 0.00% $347K $267.04
2023 Q4 REDUCED 2,500 -11,200 -81.8% 0.00% $578K $231.38
2023 Q4 ADDED 13,700 +13,100 +2183.3% 0.01% $3.2M $231.38
28 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    MDGL price (monthly, adj. close)
← Back to Walleye Trading LLC Holdings